Healthcare Sales & Marketing Network News: SIRA

Searching News Database: SIRA

HSMN NewsFeed - 2 Dec 2024
Mallinckrodt Completes Divestiture of Therakos(R) Business
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 3 Oct 2024
Avidity Biosciences Announces FDA Removed Partial Clinical Hold on Delpacibart Etedesiran (del-desiran/AOC 1001)
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Aug 2024
Mallinckrodt Reaches Agreement to Sell Therakos(R) Business to CVC for $925 Million
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 28 Jun 2024
AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY(R)) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 21 Feb 2024
Sira Medical Wins FDA Clearance for Augmented Reality Preoperative Surgical Planning Software
Devices Surgery FDA

HSMN NewsFeed - 29 Jan 2024
IceCure Medical's Breast Cryoablation Gains Prominence in the U.S., as Society of Interventional Oncology Annual Meeting Features its First Breast Cryoablation Master Class
Devices Oncology

HSMN NewsFeed - 22 Sep 2022
Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6 for the Treatment of Obesity and Cardio-Metabolic Disorders
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Aug 2022
Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 21 Jul 2022
Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO(R) (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 30 Mar 2022
Omega Therapeutics Strengthens Team With Key Management Appointments To Support Its Growth
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Mar 2022
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Final Results of the BRIGHT Phase III Clinical Trial Evaluating PRX-102 for the Treatment of Fabry Disease
Biopharmaceuticals

HSMN NewsFeed - 24 Feb 2022
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce the Submission of a Marketing Authorization Application to the European Medicines Agency for PRX-102 for the Treatment of Fabry Disease
Biopharmaceuticals Regulatory

HSMN NewsFeed - 20 Jan 2022
Alpha Tau Announces New Research Collaboration to Study the Potential of Alpha DaRT to Enhance Immune Stimulation in the Treatment of Breast Cancer
Devices Oncology

HSMN NewsFeed - 10 Jan 2022
Alpha Tau Announces Results of First US Clinical Trial of Alpha DaRT(TM) in Malignant Skin & Soft Tissue Cancers, Showing Complete Response in All Ten Treated Tumors at Approximately 12 Weeks and No Product-Related Serious Adverse Events
Devices Oncology

HSMN NewsFeed - 3 Jan 2022
Alpha Tau Announces Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck Cancer
Devices Oncology

HSMN NewsFeed - 17 Nov 2021
Alpheus Medical Closes $16M In Series A Financing For Novel Glioma Brain Cancer Treatment
Devices Oncology Venture Capital

HSMN NewsFeed - 8 Oct 2021
Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM
Devices Oncology FDA

HSMN NewsFeed - 30 Aug 2021
Poseida Therapeutics Announces FDA Clearance of Investigational New Drug Application for P-BCMA-ALLO1, an Allogeneic CAR-T Candidate for Relapsed/Refractory Multiple Myeloma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 26 Jul 2021
Medtronic Launches Newest-Generation Drug Coated Balloon Catheter in Europe for Treatment of Coronary Artery Disease
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 28 Apr 2021
Protalix BioTherapeutics and Chiesi Global Rare Diseases Receive Complete Response Letter for Pegunigalsidase Alfa from FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 23 Feb 2021
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Positive Topline Results from BRIGHT Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa 2 mg/kg every Four Weeks for Treatment of Fabry Disease
Biopharmaceuticals

HSMN NewsFeed - 11 Feb 2021
Protalix BioTherapeutics Enters into an Exclusive Partnership with SarcoMed USA to Develop alidornase alfa for the Treatment of Pulmonary Sarcoidosis and Related Respiratory Diseases Via Inhaled Delivery
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 30 Dec 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Final Results of BRIDGE Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa for the Treatment of Fabry Disease
Biopharmaceuticals

HSMN NewsFeed - 27 Nov 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Extension of PDUFA Date for Pegunigalsidase Alfa for the Proposed Treatment of Fabry Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Oct 2020
Akero Therapeutics Receives European Medicines Agency Priority Medicines (PRIME) Designation for Efruxifermin (EFX) in NASH
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 8 Jun 2020
HistoSonics Announces $40 Million Financing
Devices Venture Capital

HSMN NewsFeed - 28 May 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Submission of Biologics License Application to U.S. Food and Drug Administration for Pegunigalsidase Alfa for the Treatment of Fabry Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 11 May 2020
Protalix BioTherapeutics Announces Positive Topline Results from the BRIDGE Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa for the Treatment of Fabry Disease
Biopharmaceuticals

HSMN NewsFeed - 18 Nov 2019
Protalix BioTherapeutics and Chiesi Farmaceutici Announce Successful pre-BLA Meeting with FDA for Accelerated Approval of pegunigalsidase alfa for the Treatment of Fabry Disease in the United States
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Oct 2019
Biogen and Alkermes Announce FDA Approval of VUMERITY(TM) (diroximel fumarate) for Multiple Sclerosis
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 23 Oct 2019
Zyla Life Sciences Announces Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jun 2019
Encoded Therapeutics, Inc. Announces $104 Million Series C Financing to Advance Lead Gene Therapy Program in Dravet Syndrome and Unveils its Precision Gene Therapy Platform
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 9 Apr 2019
Innoblative's SIRA(TM) RFA Electrosurgical Device Receives FDA Clearance
Devices Surgery FDA

HSMN NewsFeed - 9 Apr 2019
Alkermes Announces Positive Topline Results From Innovative Study of ARISTADA(R) and INVEGA SUSTENNA(R) for the Treatment of Schizophrenia
Biopharmaceuticals

HSMN NewsFeed - 8 Apr 2019
HistoSonics, Non-Invasive Robotics Pioneer, Closes $54 Million Series C Financing
Devices Venture Capital

HSMN NewsFeed - 2 Apr 2019
Dr. Gustavo Mahler Resigns as Chief Executive Officer of AGC Biologics, Patricio Massera to Succeed as CEO Effective May 1st, 2019
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Feb 2019
Neovasc Provides Corporate Update
Devices Interventional Cardiology Litigation

HSMN NewsFeed - 2 Nov 2018
Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval for SYMPAZAN(TM) (clobazam) Oral Film
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 31 Oct 2018
Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 26 Oct 2018
Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio
Biopharmaceuticals Dermatology Acquisitions

HSMN NewsFeed - 9 Jul 2018
BD Acquires TVA Medical to Advance Leadership in Solutions for Chronic Kidney Disease
Devices Mergers & Acquisitions

HSMN NewsFeed - 12 Jun 2018
NuVasive Launches AttraX Scaffold Biologic And Reports First Clinical Use
Devices Orthopaedic Neurosurgery Product Launch

HSMN NewsFeed - 7 Jun 2018
Egalet Appoints Industry Veteran John Varian to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 May 2018
Egalet Announces Large Regional Plan to Cover SPRIX(R) Nasal Spray
Biopharmaceuticals Reimbursement

HSMN NewsFeed - 23 Mar 2018
Amgen Receives Positive CHMP Opinion Recognizing That Repatha(R) (evolocumab) Prevents Heart Attacks And Strokes
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 8 Mar 2018
Sanofi Completes Acquisition of Bioverativ Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 27 Dec 2017
Protalix BioTherapeutics’ PRX-102 Granted Orphan Drug Designation by the European Commission
Biopharmaceuticals Regulatory

HSMN NewsFeed - 15 Dec 2017
Egalet Receives FDA Tentative Approval for Expanded Label for ARYMO(R) ER (morphine sulfate) C-II, an Extended-Release Morphine Product Formulated with Abuse-Deterrent Properties for Treatment of Chronic Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Dec 2017
OncoTartis Closes $6M Financing Round
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 17 Nov 2017
MiMedx Market Leadership Well Positioned In Light Of FDA New Guidance Document
Regenerative Medicine FDA

HSMN NewsFeed - 6 Nov 2017
Neovasc Receives FDA Approval to Initiate Pivotal Reducer Trial
Devices Interventional Cardiology FDA

HSMN NewsFeed - 28 Jul 2017
Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR(R) NECTAR (barium sulfate) Oral Suspension
Diagnostics Radiology Gastroenterology FDA

HSMN NewsFeed - 16 Jun 2017
New Safety and Long-Term Efficacy Data from Baricitinib Clinical Trials in Patients with Moderate-to-Severe Rheumatoid Arthritis Presented at EULAR 2017
Biopharmaceuticals

HSMN NewsFeed - 22 Feb 2017
Repatha(R) (Evolocumab) Receives European Commission Approval For New 420 mg Single-Dose Delivery Option
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 18 Jan 2017
Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 11 Jan 2017
Study Results Published in the Journal of the American Medical Association Show Amgen's Parsabiv(TM) (Etelcalcetide) Significantly Reduced Serum Parathyroid Hormone in Adults With Secondary Hyperparathyroidism on Hemodialysis
Biopharmaceuticals

HSMN NewsFeed - 9 Jan 2017
The Medicines Company Announces Positive Top-Line Results from Day 180 Interim Analysis in Ongoing ORION-1 Phase 2 Study of Inclisiran (formerly, PCSK9si)
Biopharmaceuticals Cardiology

HSMN NewsFeed - 14 Dec 2016
Zimmer Biomet Strengthens Spine Offering with PrimaGen Advanced(TM) Allograft
Devices Orthopaedic Product Launch

HSMN NewsFeed - 16 Nov 2016
Aclaris Therapeutics Announces Positive Top-Line Phase 3 Results for A-101 In Treating Seborrheic Keratosis, a Common Undertreated Skin Condition
Biopharmaceuticals Dermatology

HSMN NewsFeed - 29 Aug 2016
New Repatha(R) (evolocumab) Analyses Show Efficacy and Safety Across Risk Groups in Results Presented at ESC Congress 2016
Biopharmaceuticals Cardiology

HSMN NewsFeed - 12 May 2016
Cardiome Announces the Launch of ESMOCARD Solution for Injection in France
Biopharmaceuticals Cardiology Product Launch

HSMN NewsFeed - 30 Mar 2016
Oculus Innovative Sciences and Lipogrid of Sweden Announce Strategic Collaboration for Topical Dermatology Drug Delivery
Biopharmaceuticals Drug Delivery Dermatology

HSMN NewsFeed - 21 Mar 2016
Juniper Pharmaceuticals Affirms Development Pathway for Oxybutynin Intra-vaginal Ring for Overactive Bladder in Women
Biopharmaceuticals Urology Drug Delivery FDA

HSMN NewsFeed - 18 Dec 2015
Navitor Pharmaceuticals Announces $33 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Dec 2015
Oculus Innovative Sciences Receives FDA Clearance for Microcyn(R)-Based SebDerm Gel
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 8 Dec 2015
Ignyta Receives Orphan Drug Designation in the European Union for Entrectinib for the Treatment of Neuroblastoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 23 Nov 2015
Pfizer and Allergan to Combine
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 13 Oct 2015
GTx Receives FDA Clearance to Initiate Clinical Trial in Stress Urinary Incontinence
Biopharmaceuticals Urology FDA

HSMN NewsFeed - 9 Oct 2015
Aortica Corporation Strengthens Executive Team
Devices Interventional Personnel

HSMN NewsFeed - 25 Aug 2015
Xtant Medical Announces FDA Approval of OsteoSelect(R) PLUS
Devices Regenerative Medicine Orthopaedic FDA

HSMN NewsFeed - 18 Aug 2015
WAVE Life Sciences Raises $66 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Aug 2015
GE Healthcare First to Receive FDA Clearance for Low Dose CT Lung Cancer Screening
Devices Oncology Radiology FDA

HSMN NewsFeed - 18 Dec 2014
The Medicines Company and SciClone Pharmaceuticals Establish Strategic Partnership for Two Cardiovascular Products in China
Biopharmaceuticals Cardiology Licensing

HSMN NewsFeed - 2 Jul 2014
Alnylam Elects Amy Schulman to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Jul 2014
Ipsen submits marketing authorization applications in the US and Europe for Somatuline(R) (lanreotide) in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Biopharmaceuticals Oncology

HSMN NewsFeed - 19 Jun 2014
Navitor Pharmaceuticals Launches with $23.5 Million Series A Financing for Novel Drug Discovery Targeting Cellular Nutrient Signaling to Treat Chronic Diseases and Rare Disorders
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 8 May 2014
Neovasc Hires Industry Veteran Vicki Bebeau as Vice President, Clinical Affairs
Devices Cardiology Personnel

HSMN NewsFeed - 23 Apr 2014
Steve Gex Named CEO at Focal Therapeutics
Devices Personnel

HSMN NewsFeed - 18 Apr 2014
Sanovas Fortifies Patent Estate for its "Smart Catheter" Portfolio: Resector Balloon System Patent Strengthens Vas Zeppelin(TM) Platform
Devices

HSMN NewsFeed - 26 Mar 2014
IMRIS pediatric horseshoe headrest enables iMRI for even the youngest neurosurgery patients
Devices Neurosurgery Radiology

HSMN NewsFeed - 11 Mar 2014
AngioDynamics Receives Expanded FDA Clearance for AngioVac
Devices Cardiology FDA

HSMN NewsFeed - 10 Feb 2014
Mast Therapeutics Signs Definitive Agreement To Acquire Aires Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 7 Feb 2014
Covis Pharmaceuticals Announces Its New Expanded Dosage Options of LANOXIN(R) for Cardiac Patients With Mild-to-Moderate Heart Failure
Biopharmaceuticals Cardiology

HSMN NewsFeed - 28 Jan 2014
Valiant Captivia Thoracic Stent Graft System From Medtronic Receives FDA Approval for Treating Aortic Dissections
Devices Interventional FDA

HSMN NewsFeed - 13 Jan 2014
Insys Announces Details of Product Development Pipeline
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 13 Jan 2014
Genzyme and Alnylam Expand Collaboration on Rare Genetic Diseases
Biopharmaceuticals Licensing

HSMN NewsFeed - 13 Jan 2014
Alnylam and Genzyme Form Transformational Alliance for RNAi Therapeutics as Genetic Medicines
Biopharmaceuticals Licensing

HSMN NewsFeed - 16 Dec 2013
MicroBiome Therapeutics(TM) Completes Bridge Financing
Biopharmaceuticals Endocrinology Venture Capital

HSMN NewsFeed - 26 Nov 2013
Echo Therapeutics Announces Positive CE Mark Regulatory Trial Results of Symphony(R) CGM System
Devices Monitoring Regulatory

HSMN NewsFeed - 6 Nov 2013
Neovasc Reducer(TM) Achieves Primary Endpoint in COSIRA Trial, Significantly Improving Functional Capabilities in Patients with Refractory Angina
Devices Cardiology

HSMN NewsFeed - 29 Oct 2013
AngioDynamics Achieves CE Approval for AngioVac
Devices Surgery Cardiology

HSMN NewsFeed - 26 Sep 2013
Relypsa Adds Renal Industry Veteran John P. Butler to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jul 2013
Bacterin’s OsteoSelect(R) DBM Putty Approved for Spinal Fusion Applications
Devices Orthopardic Neurosurgery FDA

HSMN NewsFeed - 12 Jul 2013
American Association Of Clinical Endocrinologists (AACE) Endorses Measurement Of Low-Density Lipoprotein Particle (LDL-P) Number
Diagnostics Endocrinology

HSMN NewsFeed - 10 Jul 2013
CryoLife Receives FDA Premarket Approval (PMA) for New Sologrip Minimally Invasive TMR Laser Fiber-Optic Delivery System
Devices Cardiology FDA

HSMN NewsFeed - 21 May 2013
Registry Data Presented at EuroPCR 2013 Confirms the Neovasc Reducer(TM) Improves Cardiovascular Parameters in Refractory Angina Patients
Devices Interventional Cardiology

HSMN NewsFeed - 23 Apr 2013
FDA Approves Second Drug in BD Simplist(TM) Prefilled Injectable Line of Products
Biopharmaceuticals Devices Drug Delivery Generics FDA

HSMN NewsFeed - 8 Feb 2013
Tranzyme Pharma Announces Exploration of Strategic Alternatives
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Nov 2012
iCAD Reports Significantly Improved Medicare Payment for Intraoperative Radiation Therapy
Devices Oncology Reimbursement

HSMN NewsFeed - 5 Nov 2012
Presentations at Leading Radiation Oncology Meeting Highlight CyberKnife Prostate Outcomes from Patients at More Than 40 Centers
Devices Oncology

HSMN NewsFeed - 29 Oct 2012
iCAD Reports Growing Adoption of Its Xoft Electronic Brachytherapy System by Leading U.S. Regional Hospitals
Devices Oncology

HSMN NewsFeed - 16 Oct 2012
AngioDynamics Completes Acquisition of Vortex Medical
Devices Interventional Mergers & Acquisitions

HSMN NewsFeed - 8 Oct 2012
AngioDynamics to Acquire Vortex Medical
Devices Mergers & Acquisitions

HSMN NewsFeed - 4 Sep 2012
Pfizer Receives EU Marketing Authorization for INLYTA(R) (Axitinib)
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 31 Aug 2012
Sophiris' Drug for Benign Prostatic Hyperplasia was Well Tolerated Using the Preferred Transrectal Route of Administration
Biopharmaceuticals Urology

HSMN NewsFeed - 21 Aug 2012
Covalon Announces FDA Clearance for SurgiClear(TM) Antimicrobial Silicone Wound Dressing
Devices Wound Care Surgery FDA

HSMN NewsFeed - 13 Jul 2012
ProTron's Cerebral Stethoscope Offers Breakthrough for Early Detection of Aneurysms
Devices

HSMN NewsFeed - 7 Jun 2012
CyberKnife(R) Prostate SBRT Outcomes and Quality of Life Data Presented at American Urological Association Meeting
Devices Oncology Urology

HSMN NewsFeed - 16 May 2012
Mitralign Raises $35 Million Series D Financing
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 15 May 2012
Covalon Announces Major Milestone: Achieves FDA Approval for IV Clear(TM) - a Breakthrough Antimicrobial Silicone Adhesive Film Dressing for Securing Vascular Access Medical Devices
Devices FDA

HSMN NewsFeed - 22 Mar 2012
Integra LifeSciences Launches New Shoulder Arthroplasty Device in Italy and Sweden
Devices Orthopaedic

HSMN NewsFeed - 15 Mar 2012
CSL Behring Announces First Patient Treated in Phase III Study of Fibrinogen Concentrate (Human)(FCH) to Control Bleeding During Aortic Aneurysm Surgery
Biopharmaceuticals Surgery

HSMN NewsFeed - 28 Feb 2012
FIRMAGON(R) (degarelix) demonstrates non-inferiority to goserelin with bicalutamide in reducing prostate volume in prostate cancer patients while providing better relief from lower urinary tract symptoms
Biopharmaceuticals Urology Oncology

HSMN NewsFeed - 5 Jan 2012
OrbusNeich's Genous(TM) Stent Achieves Good, Comparable Clinical Outcomes in Patients Discontinuing Dual Antiplatelet Therapy at 30 Days and at Six Months
Devices Interventional Cardiology

HSMN NewsFeed - 6 Dec 2011
Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony(R) Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
Devices Endocrinology Monitoring

HSMN NewsFeed - 22 Nov 2011
Pfizer to Acquire Excaliard Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 9 Nov 2011
Cerebral Stethoscope Offers New Tool for Early Detection of Aneurysms
Devices

HSMN NewsFeed - 26 Oct 2011
Covidien Launches World’s First Non-Absorbable, Uni-Directional Knotless Suture
Devices Surgery

HSMN NewsFeed - 25 Oct 2011
Aegerion Pharmaceuticals Appoints Craig E. Fraser as President, U.S.
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Oct 2011
Echo Therapeutics Announces Positive Results of Clinical Trial of Its Symphony(R) Continuous Glucose Monitoring System
Devices Monitoring

HSMN NewsFeed - 28 Sep 2011
Multi-Session Gamma Knife Radiosurgery Gaining Traction in North America to Treat Patients With Cancers in Brain and Skull Base
Devices Oncology Neurosurgery

HSMN NewsFeed - 30 Aug 2011
Accuray Drives Growth in Radiosurgery for Early-Stage Prostate Cancer
Devices Oncology

HSMN NewsFeed - 17 Aug 2011
OPKO Invests in Cardiac Device Company
Devices Interventional Cardiology

HSMN NewsFeed - 21 Jul 2011
Aegerion Pharmaceuticals Announces Appointment of Paul G. Thomas to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jul 2011
Zafgen Secures $33 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 10 May 2011
First-ever Gamma Knife in Paris Offers New Treatment Options for Patients With Cancer and Other Brain Disorders
Devices Oncology Neurosurgery

HSMN NewsFeed - 1 Apr 2011
AngioScore Launches New Longer AngioSculpt(R) Devices for Treatment of Peripheral Artery Disease
Devices Interventional FDA

HSMN NewsFeed - 30 Mar 2011
Breaking ICU Study: New, Noninvasive Alternative in Aortic Pressure Monitoring
Devices Cardiology Monitoring

HSMN NewsFeed - 22 Mar 2011
TESARO Enters into Exclusive License Agreement with Amgen to Acquire Rights to Anaplastic Lymphoma Kinase (ALK) Program
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 11 Mar 2011
Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 8 Mar 2011
VeinViewer(R) Vascular Imaging System Continues to Grow in International Health Care Market
Devices Distribution

HSMN NewsFeed - 15 Feb 2011
Aegerion Pharmaceuticals Appoints Diane L. Tribble, Ph.D., M.M.Sc., as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Feb 2011
MedShape Solutions, Inc. Announces Breakthrough in ACL Reconstruction
Devices Orthopaedic

HSMN NewsFeed - 7 Feb 2011
Aegerion Pharmaceuticals Appoints Martha J. Carter as Chief Regulatory Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jan 2011
Robert S. (“Bob”) Ward assumes full-time role as Chairman of Emergence Venture Partners, LLC
Devices Venture Capital Personnel

HSMN NewsFeed - 11 Jan 2011
First Five-Year Outcomes Published on CyberKnife Radiosurgery for Prostate Cancer
Devices Oncology

HSMN NewsFeed - 9 Dec 2010
Medtronic CoreValve(R) System Gains CE Mark for New Subclavian Approach to Transcatheter Aortic Valve Implantation
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 27 Oct 2010
Calypso Medical Initiates First Clinical Study Using Real-Time Tracking During Lung Cancer Radiotherapy
Devices Oncology

HSMN NewsFeed - 27 Sep 2010
SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jul 2010
Trevena Secures $35 Million in Series B Funding to Progress Portfolio of GPCR Biased Ligands and to Complete Phase 2 Study of TRV120027 for Acute Heart Failure
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 1 Jul 2010
Bacterin International Appoints Three New Members to Its Board of Directors
Devices Orthopaedic Personnel

HSMN NewsFeed - 3 Jun 2010
Elan Corporation, plc Board Announces CEO Agreement
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Apr 2010
OrbusNeich Announces Full Availability of Genous(TM) Bio-engineered Cobalt Chromium Stent Following CE Mark Approval
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 5 Apr 2010
Qutenza(R) (capsaicin) 8% Patch for Treatment of Post-Shingles Pain Now Available
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 30 Mar 2010
Germany's University Medical Center Mannheim Accelerates Cancer Care with Elekta's Monaco Planning Software
Devices Oncology

HSMN NewsFeed - 22 Feb 2010
FDA Acknowledges Need for Daily Multiple Sclerosis Pill by Granting Fingolimod Priority Review Status
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 11 Feb 2010
Cadence Pharmaceuticals Receives Complete Response Letter from FDA for Intravenous Acetaminophen NDA
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Feb 2010
Novus Scientific Receives FDA Clearance for TIGR(TM) Matrix Surgical Mesh - World's 1st Long-Term Resorbable Synthetic Mesh
Devices FDA

HSMN NewsFeed - 2 Feb 2010
FDA Accepts Javelin Pharmaceuticals' Submission and Files New Drug Application for Dyloject(TM)
Biopharmaceuticals FDA Mergers & Acquisitions

HSMN NewsFeed - 13 Jan 2010
Pathway Medical Technologies Receives FDA 510(k) Clearance for JETSTREAM G3 Atherectomy System
Devices Interventional FDA

HSMN NewsFeed - 11 Jan 2010
Interim Study Data Indicate Improved Blood Pressure Management With Cardene(R) I.V. Compared to Labetalol in Patients with Acute Stoke
Biopharmaceuticals Cardiology Neurology

HSMN NewsFeed - 4 Jan 2010
The Medicines Company Files Additional Patent Infringement Lawsuits
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 22 Dec 2009
The Medicines Company Acquires ApoA-I Milano From Pfizer
Biopharmaceuticals Licening

HSMN NewsFeed - 14 Dec 2009
FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Dec 2009
FDA Grants Emergency Use Authorization for DxNA's GeneSTAT(TM) Integrated PCR-based Influenza Detection System for H1N1 Virus
Diagnostics FDA

HSMN NewsFeed - 9 Dec 2009
Ellipse Technologies Announces the World's First Remote Control, Expandable/Reversible Device Used Clinically to Straighten a Human Spine
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 4 Dec 2009
FDA Approves Lilly's Zyprexa for Two Adolescent Indications
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Dec 2009
US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Nov 2009
Ellipse Technologies, Inc. Receives CE Mark Clearance for the MAGEC(TM) System for the treatment of Spinal Scoliosis
Devices Orthopaedic Neurosurgery Regulatory

HSMN NewsFeed - 11 Nov 2009
Longer Prescribed Replacement Intervals Leads to More Stretching of Frequent Replacement Contact Lenses
Devices Ophthalmology

HSMN NewsFeed - 2 Oct 2009
The Medicines Company Announces the Resignation of Its Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Aug 2009
The Medicines Company Responds to Incorrect News Reports
Biopharmaceuticals Cardiology

HSMN NewsFeed - 29 Jul 2009
Vystar(R) Corporation and Alatech Healthcare, LLC Announce FDA 510(k) Clearance for Exam Gloves Made with Vytex(R) NRL
Devices FDA

HSMN NewsFeed - 23 Jul 2009
The Medicines Company Appoints T. Scott Johnson as Vice President, New Business Ventures & Chief Medical Advisor
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jun 2009
FDA Grants The Medicines Company Pediatric Exclusivity for Angiomax(R)
Biopharmaceuticals Cardiology

HSMN NewsFeed - 11 Jun 2009
4 Top Transplant Hospitals Honored as "Best of the Best" for Total Artificial Heart
Devices Cardiology

HSMN NewsFeed - 1 Jun 2009
Study Concludes PillCam ESO(R) Correlates Well With EGD in Detecting and Grading Esophageal Varices -- A Potentially Lethal Complication of Advanced Liver Disease
Devices Gastroenterology

HSMN NewsFeed - 21 May 2009
NeurogesX Receives European Commission Approval for Qutenza(TM)
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 13 May 2009
The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program of Cangrelor
Biopharmaceuticals Cardiology

HSMN NewsFeed - 27 Apr 2009
Medtronic Starts Enrollment in THRIVE, U.S. Post-Market Study of the Talent Thoracic Stent Graft
Devices Interventional

HSMN NewsFeed - 23 Mar 2009
FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Mar 2009
NeurogesX' Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
Biopharmaceuticals Pain Management Regulatory

HSMN NewsFeed - 26 Feb 2009
The Medicines Company Completes Acquisition of Targanta Therapeutics Corporation
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 3 Feb 2009
Regenerative Medicine Company Garnet Biotherapeutics Raises $10.4 Million
Regenerative Medicine Dermatology Venture Capital

HSMN NewsFeed - 29 Jan 2009
Safeguard Scientifics Joins $10.4 Million Financing of Garnet Biotherapeutics
Regenerative Medicine Venture Capital

HSMN NewsFeed - 15 Jan 2009
Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices
Biopharmaceuticals

HSMN NewsFeed - 13 Jan 2009
The Medicines Company to Acquire Targanta Therapeutics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 12 Jan 2009
Allium Group Receives CE Mark for Its Next-Generation Prostatic Stent
Devices Urology Interventional Regulatory

HSMN NewsFeed - 8 Jan 2009
New Clinical Studies Support Broader Use of CardioNet System for the Detection of Atrial Fibrillation
Devices Cardiology

HSMN NewsFeed - 6 Jan 2009
Anacor Raises $50 Million in Equity Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 9 Dec 2008
Merck Serono's Kuvan(R) Receives Marketing Authorization in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 22 Oct 2008
Medtronic Launches New Medical Device That Improves Minimally-Invasive Treatment of Thoracic Aortic Aneurysms
Devices Interventional

HSMN NewsFeed - 7 Oct 2008
Eli Lilly and Company Resolves Investigation Involving Numerous States
Biopharmaceuticals

HSMN NewsFeed - 26 Sep 2008
CHMP Recommends Approval of Olanzapine Long-acting Injection for Maintenance Treatment of Schizophrenia in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 26 Sep 2008
Merck Serono's Kuvan(R) Recommended for European Approval
Biopharmaceuticals Regulatory

HSMN NewsFeed - 24 Sep 2008
Nice Approves Pradaxa(R)*(Dabigatran Etexilate) - First New Oral Anticoagulant in the UK for Over 50 Years
Biopharmaceuticals Regulatory

HSMN NewsFeed - 16 Sep 2008
Doctors in the US and Netherlands Using Fast RapidArc Radiotherapy Technology to Help Fight Cancer are Now Treating Tumors of the Head and Neck
Devices Oncology

HSMN NewsFeed - 15 Sep 2008
MIV Therapeutics VESTAsync(TM) Drug-Eluting Stent Trials Progress
Devices Interventional Cardiology

HSMN NewsFeed - 10 Sep 2008
Schering-Plough Announces European Launch of BRIDION(R) (Sugammadex)
Biopharmaceuticals

HSMN NewsFeed - 3 Sep 2008
New Analysis From HORIZONS-AMI Shows Major Bleeding Has a Significant Impact and Contributes to 30-Day Mortality Following Angioplasty in Severe Heart Attack Patients
Biopharmaceuticals Cardiology

HSMN NewsFeed - 2 Sep 2008
Histogenics Secures $9 Million in Second Round of Financing
Regenerative Medicine Orthopaedic Venture Capital

HSMN NewsFeed - 26 Aug 2008
ACUITY 1-Year Sub-Analysis Published in Journal of the American College of Cardiology
Biopharmaceuticals Cardiology

HSMN NewsFeed - 26 Aug 2008
New Publication Shows Cleviprex(TM) is Safe and Effective for Treatment of Acute, Severe Hypertension
Biopharmaceuticals

HSMN NewsFeed - 5 Aug 2008
Curacyte Sells Its Subsidiary Curacyte Discovery GmbH to The Medicines Company
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Aug 2008
The Medicines Company Acquires CU-2010 and Curacyte Discovery GmbH
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Aug 2008
TVM Capital Welcomes The Medicines Company in The European Market Through the Acquisition of Curacyte Discovery GmbH
Biopharmaceuticals Venture Capital Mergers & Acquisitions

HSMN NewsFeed - 5 Aug 2008
MIV Announces Excellent Safety and Efficacy of VESTAsync(TM) Polymer-Free Drug-Eluting Stent at 12-Month Clinical Follow Up
Devices Interventional Cardiology

HSMN NewsFeed - 4 Aug 2008
The Medicines Company's Cleviprex(TM) Receives FDA Approval
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Jul 2008
New Publication Shows Cleviprex(TM) is Effective for Rapid Treatment of Acute Hypertension After Cardiac Surgery
Biopharmaceuticals Cardiology

HSMN NewsFeed - 30 Jun 2008
Crystalens HD(TM) Receives FDA Approval
Devices Ophthalmology FDA

HSMN NewsFeed - 30 Jun 2008
New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 20 Jun 2008
Controlling Perioperative Hypertension with Cleviprex Reduces Risk of Heart Attack and of Death Following Cardiac Surgery, According to New Analyses
Biopharmaceuticals Cardiology

HSMN NewsFeed - 9 Jun 2008
Atrium Medical Corporation Announces First Implant of First-in-Man CINATRA(TM) Voclosporin Coated Coronary Stent
Devices Interventional Cardiology

HSMN NewsFeed - 30 May 2008
New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 May 2008
Drug-Eluting Coronary Stents Utilizing Isotechnika's Lead Drug Receive Approval to Enter Clinical Trials
Devices Interventional Cardiology

HSMN NewsFeed - 20 May 2008
MIV's Stents Subject of Two Live Cases and Several Presentations at EuroPCR
Devices Interventional Cardiology

HSMN NewsFeed - 14 May 2008
Cook Medical Launches EVOLUTION(R)-Shortie Mechanical Dilator Sheath Set for Vessel Access Associated with Lead Extraction
Devices Cardiology

HSMN NewsFeed - 6 May 2008
REGiMMUNE Raises $8,000,000 in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 May 2008
MIV Therapeutics Featured in Cardiovascular Business News
Devices Interventional Cardiology

HSMN NewsFeed - 5 May 2008
Advantage Medical Devices Receives FDA Clearance for VantageCath(TM)
Devices FDA

HSMN NewsFeed - 1 May 2008
BrachySciences Introduces AnchorSeed(TM), a Major Breakthrough in Precise, Loose-Seed Implants
Devices Oncology

HSMN NewsFeed - 29 Apr 2008
Cardium Reports on Science Channel Series Featuring InnerCool's Endovascular Cooling During Brain Surgery at Stanford University
Devices Neurosurgery

HSMN NewsFeed - 28 Apr 2008
North Park Aesthetics Acquires Exclusive Worldwide Rights to Develop and Commercialize Fluridil, a Novel Antiandrogen for Androgenetic Alopecia
Biopharmaceuticals

HSMN NewsFeed - 15 Apr 2008
Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
Devices Cardiology

HSMN NewsFeed - 31 Mar 2008
SurModics Announces First Human Use of SynBiosys(TM) Biodegradable Polymer on CardioMind Drug-Eluting Stent
Devices Interventional Cardiology

HSMN NewsFeed - 31 Mar 2008
MIV Preliminary Nine-Month Human Data Affirms Excellent Safety and Efficacy of VESTAsync(TM) Polymer-Free Drug-Eluting Stent
Devices Interventional Cardiology

HSMN NewsFeed - 20 Mar 2008
Pharming to receive Negative Opinion on European Marketing Authorization Application for Rhucin(R)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 19 Mar 2008
Cardium's InnerCool Therapies Unit Announces Australian Distribution Agreement for CoolBlue and Rapid Blue Systems
Devices Distribution

HSMN NewsFeed - 19 Mar 2008
Varian Announces Global Clinical Council to Develop RapidArc(TM) Cancer Treatments
Devices Oncology

HSMN NewsFeed - 13 Mar 2008
Echo Therapeutics Announces Positive Results from Symphony(TM) Transdermal Continuous Glucose Monitoring System Study at Tufts Medical Center
Devices Monitoring Endocrinology

HSMN NewsFeed - 13 Mar 2008
AVI BioPharma Announces Acquisition of Ercole Biotech
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 12 Mar 2008
Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
Biopharmaceuticals

HSMN NewsFeed - 4 Mar 2008
MIV Therapeutics Announces Changes to Its Scientific Advisory Board
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 28 Feb 2008
FDA Issues Not-Approvable Letter for Lilly's Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Feb 2008
FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Feb 2008
EKR Therapeutics and PDL BioPharma Sign Asset Purchase Agreement for Cardiovascular Products
Biopharmaceuticals Acquisitions Cardiology

HSMN NewsFeed - 4 Feb 2008
IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 Feb 2008
Obagi Medical Products' Solubilized Benzoyl Peroxide Provides Clinically Significant Lesion Reduction for Mild to Moderately Severe Acne
Biopharmaceuticals Dermatology

HSMN NewsFeed - 31 Jan 2008
Somaxon Pharmaceuticals Submits New Drug Application for SILENOR(TM) for the Treatment of Insomnia
Biopharmaceuticals

HSMN NewsFeed - 25 Jan 2008
IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 23 Jan 2008
Obagi Medical Products Introduces the New ELASTIderm Decolletage System
Biopharmaceuticals Dermatology

HSMN NewsFeed - 7 Jan 2008
MIV Therapeutics Appoints Mark Landy to Additional Post of Chief Executive Officer
Devices Cardiology Personnel

HSMN NewsFeed - 31 Dec 2007
IDM Pharma Announces Termination of UVIDEM Development Collaboration and Expected Restructuring in Connection With Evaluation of Strategic Alternatives
Biopharmaceuticals Oncology

HSMN NewsFeed - 21 Nov 2007
MIV Therapeutics to Sell Israeli Subsidiary SagaX
Devices Interventional

HSMN NewsFeed - 15 Nov 2007
Toshiba Announces Its Fourth Generation Contrast-Free Technique -- Time and Space Angiography (TSA)
Devices Radiology

HSMN NewsFeed - 8 Nov 2007
New Data Show MIV Therapeutic's Vestasync Drug Eluting Stent Produces Less Fibrinoid and Equivalent Efficacy When Compared to Other Stents
Devices Interventional Cardiology

HSMN NewsFeed - 6 Nov 2007
COURAGE Sub-study: PCI Outperforms Drugs-Only
Devices Interventional Cardiology

HSMN NewsFeed - 29 Oct 2007
MGI PHARMA and HELSINN Announce Submission of Supplemental New Drug Application for Aloxi(R) Capsules
Biopharmaceuticals

HSMN NewsFeed - 23 Oct 2007
Cleviprex(TM) (Clevidipine Butyrate) Rapidly Reduced Blood Pressure and Maintained Control in Study of Patients with Acute Hypertension
Biopharmaceuticals Cardiology

HSMN NewsFeed - 23 Oct 2007
New Data Show Obagi Medical Products' Nu-Derm Improves Scar Cosmesis Following Removal of Basal Cell Carcinoma versus Standard Treatment
Biopharmaceuticals Dermatology

HSMN NewsFeed - 22 Oct 2007
InnerCool Licenses New Therapeutic for Potential Use in Stroke Patients
Devices Biopharmaceuticals Cardiology Licensing

HSMN NewsFeed - 22 Oct 2007
MIV Therapeutics Announces Positive Results From First Human Study With Its VESTASYNC Stent
Devices Interventional Cardiology

HSMN NewsFeed - 19 Oct 2007
Data Show Obagi Medical Products' Solubilized Benzoyl Peroxide Gel May Provide Dramatic Reductions in Acne Lesions Within Four Weeks
Biopharmaceuticals Dermatology

HSMN NewsFeed - 16 Oct 2007
Results of First-In-Man Study With MIVT Low Dose Polymer-Free Drug-Eluting Stent to Be Presented at TCT Conference
Devices Interventional Cardiology

HSMN NewsFeed - 15 Oct 2007
Improved Perioperative Blood Pressure Control Associated with Reduced Risk of Kidney Dysfunction in Cardiac Surgery Patients
Biopharmaceuticals Cardiology Surgery

HSMN NewsFeed - 5 Oct 2007
Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
Biopharmaceuticals

HSMN NewsFeed - 4 Oct 2007
Successful Mitral Valve Repair Using Viking's 3Di Vision Systems Underscores Value of 3D Technology in Cardiac MIS Procedures
Devices Surgery

HSMN NewsFeed - 20 Sep 2007
Beaumont Patients 1st to get Next Generation of Radiation Treatment
Devices Oncology

HSMN NewsFeed - 14 Sep 2007
FDA Accepts NDA Filing for Cleviprex(TM) (Clevidipine Butyrate Injectable Emulsion) for the Treatment of Acute Hypertension
Biopharmaceuticals

HSMN NewsFeed - 12 Sep 2007
Design Engineers Help Patients Get Protein Drugs into the Body
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 10 Sep 2007
Obagi Medical Products Reorganizes International Sales and Manufacturing/Distribution Business Units
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 10 Sep 2007
Aspreva Provides Update On Lupus Nephritis Development Program
Biopharmaceuticals

HSMN NewsFeed - 29 Aug 2007
Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
Biopharmaceuticals FDA Oncology

HSMN NewsFeed - 27 Aug 2007
IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Aug 2007
IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
Devices Oncology FDA

HSMN NewsFeed - 20 Aug 2007
AngioDynamics Launches a Single Needle Radio Frequency Electrode for Multiple Small Lesion Ablations
Devices Interventional

HSMN NewsFeed - 7 Aug 2007
Abraxis BioScience Receives FDA Approval for Oxytocin Injection 10 USP Units/mL in a 30 mL Vial
Biopharmaceuticals Distribution

HSMN NewsFeed - 2 Aug 2007
Obagi Medical Products' New Study Shows CLENZIderm M.D. is Clinically Effective in the Treatment of Acne at Both Once- and Twice-Daily Dosing
Biopharmaceuticals Dermatology

HSMN NewsFeed - 31 Jul 2007
Micrus Endovascular Signs Letter of Intent to Acquire Revascularization Technology to Treat Ischemic Stroke
Devices Interventional Neurology

HSMN NewsFeed - 10 Jul 2007
OmniGuide(R) Launches the OtoBeam Flexible CO2 Laser Fiber Product Line for Otology
Devices

HSMN NewsFeed - 10 Jul 2007
Pipex Pharmaceuticals Acquires Late-Stage Oral Candidate for Dry Age-Related Macular Degeneration (AMD)
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 2 Jul 2007
Reliant Technologies Receives FDA Clearance for Fraxel re:pair(TM) Laser System
Devices Dermatology FDA

HSMN NewsFeed - 27 Jun 2007
Aspreva and Roche announce preliminary results for phase III study evaluating CellCept in lupus nephritis
Biopharmaceuticals

HSMN NewsFeed - 22 Jun 2007
FDA Approves Carnitor(R) SF (Levocarnitine) Sugar-Free Oral Solution For Patients With Carnitine Deficiency
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Jun 2007
St. Jude Medical Announces CE Mark Approval of OptiSense Pacing Lead
Devices Cardiology Regulatory

HSMN NewsFeed - 2 Jun 2007
Pharmion and MethylGene Report Preliminary Data for MGCD0103 at the 43rd American Society of Clinical Oncology (ASCO) Annual Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 31 May 2007
MIV Therapeutics Announces Start of Clinical Trial Marking First Ever Human Implantation of a Hydroxyapatite Coated Stent
Devices Interventional Cardiology

HSMN NewsFeed - 29 May 2007
Talima Therapeutics Secures $19 Million Series B
Biopharmaceuticals Drug Delivery Venture Capital

HSMN NewsFeed - 29 May 2007
IDM Pharma Names Timothy P. Walbert as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 May 2007
FDA Advisory Committee Reviews Data on IDM Pharma's Junovan(TM) (mifamurtide) for Treatment of Osteosarcoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 9 May 2007
St. Jude Medical Announces FDA Approval of the OptiSense(TM) Pacing Lead
Devices Cardiology FDA

HSMN NewsFeed - 7 May 2007
Early Results of the CellCept(R) Spare the Nephron Study Examine Kidney Function
Biopharmaceuticals

HSMN NewsFeed - 4 May 2007
IDM Pharma Appoints Robert De Vaere as Senior Vice President and CFO
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 May 2007
AVI BioPharma and Ercole Biotech Announce License and Drug Development Agreement for Duchenne Muscular Dystrophy and Beta Thalassemia
Biopharmaceuticals

HSMN NewsFeed - 1 May 2007
New Research Results Show That Investigational Drug Phenoxodiol Targets Cancer Protein, Causing Cancer Cell Death
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 Apr 2007
Cardiome Announces In-Licensing Agreement With Eli Lilly and Company
Biopharmaceuticals Licensing

HSMN NewsFeed - 25 Apr 2007
Ceragenix Commences Second in Series of Clinical Trials
Biopharmaceuticals Dermatology

HSMN NewsFeed - 24 Apr 2007
Ceragenix Announces Results from Phase IV Study of EpiCeram(TM) Meet All Primary and Secondary Endpoints
Biopharmaceuticals Dermatology

HSMN NewsFeed - 23 Apr 2007
Novadaq acquires portfolio of fluorescence endoscopy patents from Xillix
Devices Radiology Acquisitions

HSMN NewsFeed - 20 Apr 2007
UCB Announces Positive Top-Line Phase III Results for Keppra(R) as Adjunctive Therapy for Partial Onset Seizures in Paediatric Patients from One Month to Less than Four Years of Age
Biopharmaceuticals Neurology

HSMN NewsFeed - 17 Apr 2007
Sciton Announces ProFractional Launch During ASLMS
Devices Dermatology

HSMN NewsFeed - 10 Apr 2007
MIV Therapeutics Announces Addition of Eight New Approved Products Following Recent Acquisition of India-Based Stent Manufacturer
Devices Interventional Cardiology

HSMN NewsFeed - 10 Apr 2007
Synovis Life Technologies Acquires Laparoscopic Surgical Closure System
Devices Surgery Acquisitions

HSMN NewsFeed - 9 Apr 2007
MIV Therapeutics Announces Addition of Veteran Management Team Following Recent Acquisition of India-Based Biosync Scientific
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 5 Apr 2007
MIV Therapeutics Announces Pivotal Test Results Further Validating Company Stent Coatings Meet Critical FDA Fatigue Guidelines
Devices Interventional Cardiology

HSMN NewsFeed - 28 Mar 2007
Daiichi Sankyo, Inc. Announces Filing For WelChol Label Change to Include Ezetimibe Efficacy Data
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Mar 2007
Acuity Pharmaceuticals and Froptix Corporation Agree to Mergers with Public Shell; New Company to Develop and Market Drugs for Disorders of the Eye
Biopharmaceuticals Ophthalmology Mergers & Acquisitions

HSMN NewsFeed - 22 Mar 2007
First Patient Enrolled in RAPID MI-ICE Study Employing InnerCool's Endovascular Temperature Modulation Therapy for Heart Attack
Devices Cardiology

HSMN NewsFeed - 19 Mar 2007
HemCon Medical Technologies Completes $12 Million Private Equity Financing
Devices Wound Care Venture Capital

HSMN NewsFeed - 5 Mar 2007
Obagi Medical Products and Dongkook Pharmaceuticals Announce Launch of Obagi Nu-Derm System Skincare Products in South Korea
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 28 Feb 2007
Cobalis' Mexican Patent for PreHistin(TM) Allowed
Biopharmaceuticals

HSMN NewsFeed - 21 Feb 2007
REGiMMUNE Announces Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 20 Feb 2007
MIV Therapeutics Completes Acquisition of Biosync Scientific to Expand Operations and Accelerate Commercialization in Fast-Growing Markets
Devices Interventional Cardiology Mergers & Acquisitions

HSMN NewsFeed - 5 Feb 2007
Cardium and InnerCool Announce New External and Internal Patient Temperature Modulation Systems
Devices

HSMN NewsFeed - 5 Feb 2007
Amarin Announces Completion of Two Phase III Trials With Miraxion in Huntington's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 30 Jan 2007
Obagi Launches ELASTIderm, a Significant Advance in Eye Skincare
Biopharmaceuticals Dermatology

HSMN NewsFeed - 29 Jan 2007
Obagi Medical Products, Inc. Launches CLENZIderm M.D. Penetrating Acne Therapeutic System
Biopharmaceuticals Dermatology

HSMN NewsFeed - 8 Jan 2007
The Medicines Company's Cleviprex(TM) (Clevidipine) Phase III Safety Trials Meet Pre-Specified Objectives
Biopharmaceuticals

HSMN NewsFeed - 8 Jan 2007
Neurocrine Biosciences Announces Positive Results From Second Phase II Study With Its Orally Active GnRH Receptor Antagonist in Endometriosis
Biopharmaceuticals

HSMN NewsFeed - 8 Jan 2007
MIV Therapeutics Executes Private Financings for $4 Million to Support Acquisitions, Development and Distribution of Next Generation Stents
Devices Interventional Cardiology

HSMN NewsFeed - 26 Dec 2006
IDM Pharma Announces Acceptance for Review of the NDA for Junovan(TM) (Mifamurtide)
Biopharmaceuticals Oncology

HSMN NewsFeed - 18 Dec 2006
Somaxon's SILENOR(TM) Demonstrates Positive Results in Long-Term Phase 3 Clinical Trial in Elderly Patients with Insomnia
Biopharmaceuticals

HSMN NewsFeed - 14 Dec 2006
MIV Therapeutics Announces Market Launch of the GenX CrCo Stent and Seven Associated Interventional Cardiology Products by Biosync Scientific
Devices Interventional Cardiology

HSMN NewsFeed - 11 Dec 2006
MIV Therapeutics Executes Milestone Agreement to Acquire Biosync Scientific, a Leading Indian Interventional Cardiology Company
Devices Mergers & Acquisitions Interventional Cardiology

HSMN NewsFeed - 6 Dec 2006
BSD Medical Announces Completion of 340 Patient Cancer Study
Devices Oncology

HSMN NewsFeed - 29 Nov 2006
MIV Therapeutics Announces Company's Biocompatible Stents Matches or Outperforms World's Leading Drug-Eluting Stent in Key Categories
Devices Interventional Cardiology

HSMN NewsFeed - 27 Nov 2006
GE Healthcare Launches Volume CT Scanner; Cardiac Imaging Technology Includes Outstanding Image Quality and Reduced Dose Exposure for Patients
Devices Radiology

HSMN NewsFeed - 20 Nov 2006
Somaxon Pharmaceuticals' SILENOR(TM) Demonstrates Positive Results in Its Third Phase 3 Clinical Trial in Insomnia
Biopharmaceuticals

HSMN NewsFeed - 15 Nov 2006
FDA Clears GORE PROPATEN Vascular Graft
Devices FDA

HSMN NewsFeed - 14 Nov 2006
New Data on Otsuka's Investigational Product for Hyponatremia Presented at American Heart Association Annual Meeting
Biopharmaceuticals Cardiology

HSMN NewsFeed - 7 Nov 2006
IDM Pharma Submits Filing for European Market Approval of Mepact(TM) (mifamurtide, Junovan(TM) in the US) in the Treatment of Osteosarcoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 1 Nov 2006
Inspire and FAES Farma Announce Licensing Agreement for New Oral Antihistamine to Target Allergy Market in United States and Canada
Biopharmaceuticals LIcensing

HSMN NewsFeed - 30 Oct 2006
Mathematical Model Based on Clinical Findings From Cervarix(TM), GSK's Cervical Cancer Candidate Vaccine, Suggests Vaccination Could Reduce Cervical Cancers by up to 80%
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 Oct 2006
MIV Therapeutics Announces Timeline for First Human Implantation of HAp NanoFilm Coated Stent
Devices Interventional Cardiology

HSMN NewsFeed - 26 Oct 2006
Aspreva Pharmaceuticals Announces Preliminary Results of Phase III Trial of CellCept for Myasthenia Gravis
Biopharmaceuticals

HSMN NewsFeed - 26 Oct 2006
IDM Pharma Submits New Drug Application to the FDA for Junovan(TM) (mifamurtide) in the Treatment of Osteosarcoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 24 Oct 2006
Cardium Reports on Positive Effects of Hypothermia Following Heart Attack and Announces Clinical Study to Be Co-Sponsored by Swedish Cardiology Center
Devices Interventional Cardiology

HSMN NewsFeed - 24 Oct 2006
Acuity Pharmaceuticals Appoints Denis O'Shaughnessy Senior Vice President of Clinical Development
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 23 Oct 2006
MIV Therapeutics to Detail Research Results Showing Excellent Performance of Breakthrough Stent Coatings at TCT Conference
Devices Interventional Cardiology

HSMN NewsFeed - 23 Oct 2006
Somaxon Pharmaceuticals' SILENOR(TM) Demonstrates Positive Results in a Phase 3 Transient Insomnia Clinical Trial
Biopharmaceuticals

HSMN NewsFeed - 22 Oct 2006
XenoPort Announces Positive Results From XP19986 Phase 2a Trial in Patients with Gastroesophageal Reflux Disease
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 16 Oct 2006
Hana Biosciences Licenses Drug Candidate for the Prevention and Treatment of EGFR Inhibitor-Associated Skin Rash
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 6 Oct 2006
Coapt Systems Launches Endotine Ribbon
Devices Surgery

HSMN NewsFeed - 21 Sep 2006
Dr. Michael Morgan Reports on Benefits of InnerCool's Celsius Control System in Inducing Hypothermia During Aneurysm Surgery
Devices Neurosurgery

HSMN NewsFeed - 21 Sep 2006
MIV Therapeutics Appoints Montreal Heart Institute Interventional Cardiologist Dr. Raoul Bonan to Guide Clinical Programs
Devices Personnel

HSMN NewsFeed - 14 Sep 2006
MIV Therapeutics Names Harvard Interventional Cardiologist Dr. Joseph Carrozza to Scientific Advisory Board
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 13 Sep 2006
MIV Therapeutics Enters into Agreement to Acquire Vascore Medical Co. Ltd., Leading Chinese Manufacturer of Advanced Cardiovascular Stents
Devices Interventional Mergers & Acquisitions

HSMN NewsFeed - 12 Sep 2006
Javelin Pharmaceuticals, Inc. To Present Final Analysis of Phase 2b Study Results of Dyloject(TM) at Prestigious European Pain Conference - September 14, 2006
Biopharmaceuticals

HSMN NewsFeed - 11 Sep 2006
The Medicines Company Completes Clevidipine Phase III Safety Trials and Initiates Phase III Severe Hypertension Trial
Biopharmaceuticals Cardiology

HSMN NewsFeed - 7 Sep 2006
Amgen Launches Aranesp(R) (Darbepoetin Alfa) Prefilled SureClick(TM) Autoinjector for Treatment of Anemia Associated with Chemotherapy and Chronic Kidney Disease
Biopharmaceuticals

HSMN NewsFeed - 6 Sep 2006
Merit Medical Introduces Resolve(R) Drainage Catheter
Devices Interventional

HSMN NewsFeed - 19 Jul 2006
Somaxon Pharmaceuticals Provides Update on SILENOR(TM) Development Program for the Treatment of Insomnia
Biopharmaceuticals

HSMN NewsFeed - 11 Jul 2006
FDA Approves EMEND(R) (aprepitant), Merck's Antiemetic Therapy, for the Prevention of Postoperative Nausea and Vomiting
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Jul 2006
MIVT Cites Growing Body of Scientific Evidence Validating Company's Strategy to Create Safer, Better Cardiovascular Stents
Devices Interventional

HSMN NewsFeed - 26 Jun 2006
ev3 Receives FDA Clearance for SpideRX(TM) Embolic Protection Device for Saphenous Vein Graft Angioplasty
Devices Interventional FDA

HSMN NewsFeed - 26 Jun 2006
New Data Show FUZEON(R) Continues to Provide Significant Immune System Benefits in Patients Despite Ongoing Viral Replication
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 1 Jun 2006
Acuity Pharmaceuticals Reports Positive Initial Phase II Results for Bevasiranib (Cand5) in Wet AMD
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 1 Jun 2006
Ablynx Strengthens Management Team - Eva-Lotta Allan Joins as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 May 2006
MIV Therapeutics Establishes U.S. Corporate Headquarters with Opening of New Offices in Atlanta, GA
Biopharmaceuticals

Return to NewsFeed

Additional items found! 172

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 172 additional stories matching:
SIRA
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.